Company intelligence / Profile preview

Nevakar Inc.

Bridgewater, New Jersey, USAnevakar.com ↗

Ownership: Private
Employees: ~33
Development stage: NDA

Overview

Nevakar focuses on developing novel injectable and ophthalmic formulations by enhancing existing approved drugs to address unmet medical needs with improved clinical outcomes. Their approach leverages patent-protected innovations around drug delivery technologies, aiming at better patient care solutions especially in hospital settings.

Therapeutic areas: OtherOphthalmologyNeurology
Modalities: Injectable pharmaceuticalsOphthalmic drugsLong acting injectablesFocus on reformulated existing molecules for enhanced delivery and efficacy
Industry: Biotech

Drug pipeline

1 asset

NVK016

Unknown

Beyond the preview

Go deeper on Nevakar Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nevakar Inc..

Explore the full profile